Shelter Pharma Share Price | Shelter Pharma Stock Screener
SHELTER
Pharmaceuticals
Track Shelter Pharma share price live with TickJournal's free stock screener.
Analyse SHELTER share price data and track historical price performance.
Use the Shelter Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Shelter Pharma Market Cap
₹50.19 Cr.
SHELTER P/E Ratio (TTM)
-
Shelter Pharma P/B Ratio
0.66
EPS (TTM)
₹6.57
Dividend Yield
-
Debt to Equity
0.02
SHELTER 52 Week High
-
Shelter Pharma 52 Week Low
-
Operating Margin
-
Profit Margin
-
SHELTER Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹84.00
Total Equity
₹73.00
Shelter Pharma Share Price Chart
Screen Shelter Pharma share price with an interactive chart. Analyse SHELTER price trends and volatility across different timeframes.
Shelter Pharma Company Profile - Fundamental Screener
Screen Shelter Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SHELTER shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE013V01011
Shelter Pharma Balance Sheet Screener
Screen SHELTER balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 84 | 48 | 38 | 21 | 13 | 10 | 11 |
| Current Assets | 55 | 33 | 30 | 19 | 10 | 8 | 8 |
| Fixed Assets | 7 | 6 | 4 | 2 | 2 | 2 | 2 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 73 | 43 | 36 | 15 | 9 | 7 | 7 |
| Share Capital | 17 | 12 | 12 | 8 | 1 | 1 | 1 |
| Reserves & Surplus | 56 | 31 | 24 | 7 | 8 | 7 | 7 |
Shelter Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Shelter Pharma income statement and profit fundamentals.
Analyze SHELTER quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Shelter Pharma share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 73 | 51 | 40 | 36 | 30 | 23 | 30 |
| Expenses | 0 | 60 | 41 | 32 | 28 | 27 | 22 | 30 |
| EBITDA | 0 | 13 | 10 | 9 | 8 | 3 | 0 | 0 |
| Operating Profit % | 0.00% | 17.00% | 20.00% | 21.00% | 22.00% | 10.00% | 1.00% | 1.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 12 | 10 | 8 | 7 | 3 | 0 | 0 |
| Tax | 0 | 3 | 2 | 2 | 2 | 1 | 0 | 0 |
| Net Profit | 0 | 9 | 7 | 6 | 5 | 2 | 0 | 0 |
| EPS | 0.00 | 6.57 | 6.26 | 5.36 | 6.72 | 42.54 | 0.88 | 1.77 |
Shelter Pharma Cash Flow Screener - Liquidity Fundamentals
Screen SHELTER cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2017-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 6 | -2 | 0 | 1 | 0 | 0 | 0 |
| Investing Activities | -7 | -4 | 0 | -1 | 0 | 0 | 0 |
| Financing Activities | 0 | 11 | 0 | 0 | 1 | 0 | 0 |
| Net Cash Flow | -2 | 5 | 0 | 0 | 0 | 0 | 0 |
Shelter Pharma Shareholding Pattern Screener
See Shelter Pharma shareholding pattern with promoter, FII, and DII holdings.
Check Shelter Pharma promoter holding and ownership changes for SHELTER on TickJournal.
| Item | 2026-May | 2026-Mar | 2025-Nov | 2025-Oct | 2025-Sept | 2025-Aug | 2025-Mar | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 44.38% | 44.38% | 47.19% | 46.98% | 52.32% | 52.32% | 52.32% | 54.97% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 51.46% | 51.46% | 49.32% | 48.66% | 42.82% | 42.69% | 43.24% | 40.12% |
| Other Holding | 4.16% | 4.16% | 3.49% | 4.36% | 4.86% | 4.99% | 4.44% | 4.91% |
| Shareholder Count | 1,076 | 1,071 | 1,093 | 1,094 | 1,094 | 1,109 | 1,153 | 1,119 |
Shelter Pharma Share Dividend Screener - Share Yield Analysis
Check Shelter Pharma dividend history with payout and yield data.
View Shelter Pharma dividend details including ex-dates and amounts for SHELTER stock.
Shelter Pharma Stock Index Membership
See which indices include Shelter Pharma stock.
Check SHELTER index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Shelter Pharma Market Events Screener - Corporate Actions
Get Shelter Pharma corporate actions including splits, bonuses, and buybacks.
Check Shelter Pharma stock events that may affect SHELTER share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.35 /share | -3.84% | ||
| Annual General Meeting | NA | 1.13% | ||
| Dividend | ₹ 0.33 /share | 2.64% | ||
| Annual General Meeting | NA | -2.22% | ||
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | -3.23% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 0.87% |
| 2025-07-23 | 2025-07-23 | Extraordinary General Meeting | NA | 11.04% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 3.95% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | 0.58% |
Shelter Pharma Competitors Screener - Peer Comparison
Screen SHELTER competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 446,876 | 39.04 | 58,220 | 6.38% | 11,565 | 60.32 |
| Divis Laboratories | 174,652 | 67.84 | 10,560 | 8.73% | 2,520 | 44.73 |
| Torrent Pharmaceuticals | 156,365 | 73.76 | 13,886 | 20.34% | 2,138 | 62.27 |
| Cipla | 118,382 | 30.41 | 29,045 | 2.24% | 3,870 | 69.96 |
| Dr Reddys Laboratories | 113,273 | 27.63 | 33,593 | -0.44% | 3,998 | 66.21 |
| Zydus Life Science | 111,954 | 22.03 | 26,720 | 13.65% | 5,242 | 62.64 |
| Lupin | 110,605 | 20.55 | 27,488 | 19.98% | 5,345 | 68.05 |
| Mankind Pharma | 105,132 | 52.96 | 14,278 | 12.03% | 1,750 | 64.79 |
| Aurobindo Pharma | 90,835 | 25.68 | 33,385 | 3.21% | 3,376 | 69.05 |
| Laurus Labs | 81,918 | 91.20 | 6,868 | 22.01% | 890 | 72.35 |
Shelter Pharma Company Announcements - News Screener
Screen SHELTER latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-03 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-06-26 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-06-17 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-06-16 | Corrigendum To Intimation Of H2 FY2026 Investor Conference Call | - |
| 2026-06-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-08 | Corrigendum To Intimation Of H2 FY2026 Investor Conference Call Withdrawal Of Scheduled Meeting | - |
| 2026-06-08 | Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015- Completion And Commencement Of Dispatch Of Export Order | - |
| 2026-06-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-03 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015- Receipt Of Good Manufacturing Practices Certificate | - |
| 2026-06-02 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015-Receipt Of Renewal Manufacturing Licence | - |
| 2026-05-28 | Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-28 | Outcome Of The Board Meeting And Submission Of The Audited Standalone Financial Results For The Half Year And Year Ended March 31 2026 | - |
| 2026-05-28 | Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Audited Standalone Financial Results For The Half Year And Year Ended March 31 2026. | - |
| 2026-05-22 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 28Th May 2026 | - |
| 2026-05-19 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015-Continuous Positive Customer Feedback On Company Products | - |
| 2026-05-18 | Intimation Under Regulation 30 Of SEBI ( LODR ) Regulations 2015 - Participation In Iphex 2026 International Pharmaceutical Exihibition | - |
| 2026-05-15 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 Receipt Work Order Pursuant To Tender Process. | - |
| 2026-05-13 | Intimation Under Regulation 30 For Successfully Conducted A CME Programme In Patna Bihar On 11Th May 2026 | - |
| 2026-05-11 | Intimation Under Regulation 30 Of SEBI (LODR) Regulation 2015- New Product Launch. | - |